MINNEAPOLIS, MN (1/12/26) — A newly published manuscript authored by Dr. Gunda Georg, YourChoice Therapeutics and Columbia University Medical Center describes the chemical journey of YCT-529, a ...
A newly published manuscript authored by Dr. Gunda Georg, YourChoice Therapeutics and Columbia University Medical Center describes the chemical journey of YCT-529, a non-hormonal male birth control ...
YourChoice Therapeutics, working with Quotient Sciences and Incyte, reports that single oral doses of the investigational non‑hormonal male contraceptive YCT‑529 up to 180 mg produced no clinically ...
SAN FRANCISCO--(BUSINESS WIRE)--YourChoice Therapeutics, Inc., pioneering hormone-free family planning products, today announced that Communications Medicine, a Nature Portfolio Journal, published the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results